E.I. du Pont de Nemours and Co. (DD) Closes 1.05% Down on the Day for January 12

Equities Staff  |

Dow Jones component E.I. du Pont de Nemours and Co. (DD) saw its stock move -1.05% to $58.56, representing a per-share move of $0.62, on volume of 3.44 million shares for Tuesday.

E.I. du Pont de Nemours and Co. currently has a total float of 876.41 million shares and moves 6.91 million a day, on average. The stock opened at $59.55 on January 12 and traded between a low of $57.85 and a high of $59.87. The stock now has a 50-day SMA of $66.07 and 200-day SMA of $62.10, and it has a high of $80.65 and low of $47.11 over the last year.

E I du Pont de Nemours & Company is a science and engineering company that offers products and patents applications for agriculture, nutrition, electronics and communications, safety and protection, home and construction, transportation and apparel.

Based out of Wilmington, DE, E.I. du Pont de Nemours and Co. has 63,000 employees and is helmed by CEO Edward D. Breen.

For a deeper dive into the fundamentals of E.I. du Pont de Nemours and Co., check out equities.com’s E.V.A. report for DD.


The Dow Jones Industrial Average is the oldest and most-often cited stock market index for the American equities market. While it’s arguably outdated and inefficient, it remains the most visible representation of the stock market to the outside world. Consisting of 30 companies selected by the editorial board of the Wall Street Journal, it’s meant to give an overview of stock performances by looking at a slice of those mega- and large-cap companies deemed to best represent the broad economy.

The history of the index dates all the way back to 1896 when it was first created by Charles Dow, the legendary founding editor of the Wall Street Journal and founder of Dow Jones & Company, and Edward Jones, a statistician. The price-weighted, scaled index has since become a standard part of most major daily news recaps and has seen dozens of different companies pass through its ranks, with only General Electric (GE) remaining on the index since its inception.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor, Equities.com; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.